Company Filing History:
Years Active: 2012-2025
Title: Feenagh Keyes: Innovator in Antibody Development
Introduction
Feenagh Keyes is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 6 patents to her name, her work has had a substantial impact on medical treatments.
Latest Patents
One of her latest patents focuses on "Antibodies to ticagrelor and methods of use." This disclosure provides antibodies and antigen binding fragments that specifically bind to ticagrelor and its metabolites. The patent also includes compositions comprising these antibodies, nucleic acid molecules encoding them, and methods for treating patients through the administration of these antibodies. This innovative approach has the potential to enhance therapeutic strategies for patients requiring ticagrelor treatment.
Career Highlights
Feenagh Keyes is currently associated with Medimmune Limited, where she continues to advance her research and development efforts. Her work at Medimmune has positioned her as a key player in the biotechnology sector, contributing to the development of novel therapeutic solutions.
Collaborations
Throughout her career, Feenagh has collaborated with notable professionals in her field, including Sven Nylander and Mark Penney. These collaborations have further enriched her research and expanded the scope of her innovations.
Conclusion
Feenagh Keyes is a trailblazer in the field of antibody development, with a focus on improving patient outcomes through innovative treatments. Her contributions to biotechnology are noteworthy, and her ongoing work promises to lead to further advancements in medical science.